Statement: the primary trial participants recieve doses of Pralatrexate that are calculated based on bodyweight. panoramic is a wide angle view.
Primary_evidence: INTERVENTION 1:    Pralatrexate   Study drug 190 mg/m^2 for 2 to 4 weeks.